At neuroCare, we offer sustainable outcomes in therapy for mental disorders, chronic pain and for rehabilitation. The individualised therapy concepts offered at neuroCare clinics are achieved by integrating the expertise of mental health therapists with leading neuromodulation technology. At neuroCademy we educate clinicians and researchers in the area of neuromodulation technologies and how to apply them in daily clinical practice. Development in research and patient care is anchored by the neuroConn technology brand, a global leader and industry pioneer in non-invasive neuromodulation technology.
Everything we do, think or feel is a memorized pattern in our brain or muscle memory. Neuromodulation helps to reprogram those patterns by training our mind to more positive behaviour or for better cognitive performance. Behavourial, cognitive or motor disturbances can be treated faster and more efficiently when neurotechnology and the therapist work in synergy. Our integrated approach (i.e. cognitive therapy combined with individualised neurotherapy) shows an efficacy of 75 % for patients with ADHD and an efficacy of 78 % for patients with depression. This is a fact we are truly proud of.
At neuroCare, we also apply neurotechnologies in the diagnosis of mental disorders allowing the therapist to personalize the treatment to the patient’s individual need - this is called prognostics. Most current treatments in mental health or neurology, particularly psychopharmaceuticals, still rely on a one-size-fits-all approach. Individual differences are ignored even though not all patients have the same underlying cause for their symptoms. Our integrated and personalized approach to therapy is needed. neuroCare is a leader in the fast growing neurotherapy market.
Location: Germany, Bavaria, Munich
Total raised: $17.13M
Investors 4
Date | Name | Website |
- | bm-t betei... | bm-t.de |
- | Passion In... | passioninn... |
- | aescuvest | aescuvest.... |
- | re.Mind Ca... | remind.vc |
Funding Rounds 1
Date | Series | Amount | Investors |
24.04.2024 | - | $17.13M | - |
Mentions in press and media 11
Date | Title | Description | Source |
29.04.2024 | neurocare bekommt 16 Millionen – Deltia erhält 4,5 Millionen... | Im #DealMonitor für den 29. April werfen wir einen Blick auf die wichtigsten, spannendsten und inter... | deutsche-s... |
25.04.2024 | TVM Capital Healthcare led $ 17 M received by mental health ... | The Munich-based neurocare group AG (neurocare), a pioneer in individualized mental health care that... | incubees.c... |
24.04.2024 | Breaking Boundaries: neurocare's Global Expansion | neurocare, a Munich-based mental health company, secures a hefty EUR 16M in funding from TVM Capital... | parsers.vc... |
24.04.2024 | German mental health platform neurocare raises €16M | TVM Capital Healthcare has announced a €16M investment into Munich-based neurocare, a digital therap... | tech.eu/20... |
24.04.2024 | neurocare Raises EUR 16M in Funding | neurocare, a Munich, Germany-based personalized mental health care company, raised EUR 16M in fundin... | finsmes.co... |
- | neuroCare Group secures investment from bm|t to fund next gr... | neuroCare´s mission is to empower clinicians with an evidence-based approach to integrate neur... | bm-t.de/en... |
- | neurocare and MAG & More are joining forces | neurocare and MAG & More are very pleased to announce the integration of MAG & More into... | bm-t.de/en... |
- | neurocare announces financing round with bm|t and strategic ... | As another key step towards its planned public listing, neurocare is very pleased to announce th... | bm-t.de/en... |
- | neurocare group | “Learn more about the tools, technology and network of clinics delivering effective and sustainable ... | fastfounde... |
- | neuroCare Group receives 2nd investment from bm|t to fund fu... | neuroCare is pleased to announce the closing of a seven-figure investment with Kyowa Pharmace... | bm-t.de/en... |
Show more